Kiniksa Pharmaceuticals International KNSA Earnings Call Transcripts

NASDAQ KNSA
$95.02 -3.74 (-3.79%)
At close: Nov 10, 2026 · 4:00 PM EST
4 earnings calls on file for Kiniksa Pharmaceuticals International, from Q3 2025 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Kiniksa Pharmaceuticals International Q3 2026 Earnings Call

Oct 27, 2026 4,576 words · 20 min read
  • Jonathan KirshenbaumInvestor Relations
  • Sanj K. PatelChief Executive Officer
  • Ross MoatPresident and Chief Operating Officer
  • Mark RagosaChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Kiniksa Pharmaceuticals International Earnings Call Transcripts

Calls4
LatestOct 27, 2026
SinceQ3 2025

Fiscal 2026

Fiscal 2025

All 4 Kiniksa Pharmaceuticals International transcripts Register to get access to Kiniksa Pharmaceuticals International’s earnings call transcripts.